Eureka Biotech Call for Projects

Innovation Open Call 25 Sep 2026 Multiple Countries Innosuisse Swiss Innovation Agency
Description Informations
Description
Status
Open Call
Deadline
25 Sep 2026
Type
Innovation
Countriess
Austria, Belgium, Canada, Chile, Estonia, France, Germany, Lithuania, Netherlands, Portugal, South Africa, South Korea, Spain, Sweden, Turkey
Institution
Innosuisse Swiss Innovation Agency
Call Details

As part of the Eureka initiative, Swiss companies and research institutes are invited to undertake R&D projects focusing Biotech at an international level.

The countries taking part in this call for projects include Austria, Belgium (Wallonia and Flanders), Canada, Chile, Estonia, France, Germany, Lithuania, The Netherlands, Portugal, South Africa, South Korea, Spain, Sweden, Switzlerand and Türkiye. Your R&D project must include at least two organisations based in at least two of the countries participating in this cooperative call for projects.

Project applications with a clear innovation content and implementation plan in biotech areas like medicine, bioinformatics, pharmaceutical products and services, life sciences, digitalization, (bio)process technology (non-exhaustive list of cooperation areas) are welcome. Check call outline for topics and scope.

Schedule:

31 March 2026

Call launch
6 May 2026 Eureka GIS event Basel
25 September 2026 Deadline for submission of the full application
15 December 2026 Notification of the results of the assessment*
(*National funding procedures will be finalised/communicated until Q1/2027)

More information:

You can visit the Eureka’s dedicated webpage for more information about the call scope and details.

To submit an application:

Participants must submit their application via the Eureka Smart Simple platform.

Swiss participants must also submit their application to Innosuisse via its application platform.

Important: submissions to both the Eureka Smart Simple platform and the Innosuisse platform are required by 25 September 2026.

Please consult the guidelines and the needed financial documents here: